Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection Read more about Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection Hong Kong42024088832.1Filed on 2024-03-15
SARS-COV-2 SPIKE FUSED TO HEPATITIS B SURFACE ANTIGEN Read more about SARS-COV-2 SPIKE FUSED TO HEPATITIS B SURFACE ANTIGEN US Application 18/709,441Filed on 2024-05-10
NEUTRALIZING ANTIBODIES TO PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN AND THEIR USE Read more about NEUTRALIZING ANTIBODIES TO PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN AND THEIR USE US Application 18/707,305Filed on 2024-05-03
HIV-1 ENVELOPE TRIPLE TANDEM TRIMERS AND THEIR USE Read more about HIV-1 ENVELOPE TRIPLE TANDEM TRIMERS AND THEIR USE Patent Cooperation TreatyPCT/US2024/031661Filed on 2024-05-30
LENTIVIRAL VECTORS USEFUL FOR THE TREATMENT OF DISEASE Read more about LENTIVIRAL VECTORS USEFUL FOR THE TREATMENT OF DISEASE US Application 18/288,358Filed on 2023-10-25
LENTIVIRAL VECTORS USEFUL FOR THE TREATMENT OF DISEASE Read more about LENTIVIRAL VECTORS USEFUL FOR THE TREATMENT OF DISEASE China202280037491.XFiled on 2022-04-26
NEUTRALIZING ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN AND THEIR USE Read more about NEUTRALIZING ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN AND THEIR USE US Application 18/619,995Filed on 2024-03-28
AUGMENTATION OF INNATE AND ADAPTIVE IMMUNITY BY INHIBITION OF INTERACTION OF LILRBS WITH MHC-1 Read more about AUGMENTATION OF INNATE AND ADAPTIVE IMMUNITY BY INHIBITION OF INTERACTION OF LILRBS WITH MHC-1 European Patent22803142.3Filed on 2024-05-03
AUGMENTATION OF INNATE AND ADAPTIVE IMMUNITY BY INHIBITION OF INTERACTION OF LILRBS WITH MHC-1 Read more about AUGMENTATION OF INNATE AND ADAPTIVE IMMUNITY BY INHIBITION OF INTERACTION OF LILRBS WITH MHC-1 US Application 18/699,057Filed on 2024-04-05
Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection Read more about Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection Hong Kong42024087670.6Filed on 2024-02-26